| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/10/2002 | US6448379 Inhibitors to il8 receptor binding, including antibodies, that interact with the amino-terminal extracellular domain of the il8 receptor and compete with il8 and other related natural ligands, for receptor-binding. |
| 09/10/2002 | US6448284 Substituted tricyclics |
| 09/10/2002 | US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 09/10/2002 | US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 09/10/2002 | US6448247 Tachykinin receptor antagonist; especially to the receptors for substance p (which receptors are generally referred to as ?neurokinin 1 receptors?) |
| 09/10/2002 | US6448245 Methods of and compounds for inhibiting calpains |
| 09/10/2002 | US6448079 Inhibiting the expression of p38 mitogen activated protein kinase in cells or tissues comprising contacting said cells or tissues in vitro with the antisense compound |
| 09/10/2002 | US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | CA2258661C Synthetic phosphopeptides for treating bone diseases |
| 09/06/2002 | WO2002068650A2 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | WO2002068585A2 Tip39 polypeptides |
| 09/06/2002 | WO2002068476A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
| 09/06/2002 | WO2002068440A1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 09/06/2002 | WO2002068439A1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 09/06/2002 | WO2002068427A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 09/06/2002 | WO2002068425A1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
| 09/06/2002 | WO2002068421A2 Tricyclic compounds and their analogs as inhibitors of cytokine signaling |
| 09/06/2002 | WO2002068420A1 Xanthine derivative, production and use thereof as a medicament |
| 09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2002 | WO2002068410A1 Substituted pyrimidinone derivatives as ligands of integrin receptors |
| 09/06/2002 | WO2002068407A1 Benzimidazole compound |
| 09/06/2002 | WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 09/06/2002 | WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | WO2002068393A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/06/2002 | WO2002068388A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002068381A2 Aryl-n-cyanoguanidines and methods related thereto |
| 09/06/2002 | WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 09/06/2002 | WO2002068056A2 Combination comprising a 1,4-dioxonaphathalene compound and ribenoside |
| 09/06/2002 | WO2002067978A1 Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp |
| 09/06/2002 | WO2002067950A1 Vascular regeneration promoters |
| 09/06/2002 | WO2002067939A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | WO2002067932A1 Antihelminthic drugs as a treatment for hyperproliferative diseases |
| 09/06/2002 | WO2002067925A1 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 09/06/2002 | WO2002067919A1 Il-8 receptor antagonists |
| 09/06/2002 | WO2002067866A2 Piperazine derivatives as metalloprotease inhibitors |
| 09/06/2002 | WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 09/06/2002 | WO2002067851A2 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | WO2002067760A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 09/06/2002 | WO2002050029A3 Tetracyclic derivatives as spla2 inhibitors |
| 09/06/2002 | WO2002043648A8 Compounds active at the glucocorticoid receptor ii |
| 09/06/2002 | WO2002040517A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002040037A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002038563A3 Condensed pyrazindione derivatives as pde inhibitors |
| 09/06/2002 | WO2002017890A3 Treatment of arthritis and compositions therefore containing a n-acylated-2-glucosamine derivative |
| 09/06/2002 | WO2002016574A3 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 09/06/2002 | WO2002012250A3 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 09/06/2002 | WO2002010348A3 Tissue implant for cartilage repair |
| 09/06/2002 | WO2002010217A3 Endothelial cell expression patterns |
| 09/06/2002 | WO2002005859A3 Radiotherapy |
| 09/06/2002 | WO2002002629A3 Grf2-binding proteins and applications thereof |
| 09/06/2002 | WO2001094612A3 Method for identifying medically valuable active substances |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001031021A9 Multiple sclerosis-related superantigen |
| 09/06/2002 | WO2001015553A9 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 09/06/2002 | WO2001012674A9 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 09/06/2002 | WO2001005944A9 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | CA2674673A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2475454A1 Aryl-n-cyanoguanidines and methods related thereto |
| 09/06/2002 | CA2439463A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | CA2439265A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | CA2438934A1 Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp |
| 09/06/2002 | CA2438238A1 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2437218A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2434727A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2434666A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/06/2002 | CA2434654A1 Antihelminthic drugs as a treatment for hyperproliferative diseases |
| 09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | CA2426538A1 Tricyclic compounds and their uses |
| 09/05/2002 | US20020123652 2-aminotetralines and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 09/05/2002 | US20020123638 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin D compounds |
| 09/05/2002 | US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker |
| 09/05/2002 | US20020123614 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 09/05/2002 | US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/05/2002 | US20020123507 Bicyclic derivatives |
| 09/05/2002 | US20020123501 Useful for premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food |
| 09/05/2002 | US20020123500 CSAIDs.TM block cytokine production; use of a cytokine inhibitor for the treatment of chronic diseases which are caused by inappropriate angiogenesis, such as diabetic retinopathy, tumors, atherosclerosis and arthritis |
| 09/05/2002 | US20020123496 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 09/05/2002 | US20020123493 For therapy and prophylaxis of neuronal damage |
| 09/05/2002 | US20020123492 Beta-amino acid derivatives |
| 09/05/2002 | US20020123488 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 09/05/2002 | US20020123484 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease |
| 09/05/2002 | US20020123459 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 09/05/2002 | US20020123099 Highly expressible genes |
| 09/05/2002 | US20020122836 Extract of Arales, Asterales, Coniferales, Equisetales, Euphorbiales, Geraniales, Lamiales, Lillales, Pteridophyta, Ranales, Rhamnales, Rutales, Scrophulariales, Umbellales, or Urticales. |
| 09/05/2002 | US20020122833 Herbal compositions for treating immunological disorders |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236477A2 A formative agent of protein complex |
| 09/04/2002 | EP1236475A2 Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue |
| 09/04/2002 | EP1236473A2 Self-assembling polynucleotide delivery system |
| 09/04/2002 | EP1236468A1 Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders |
| 09/04/2002 | EP1236044A2 Diagnosing and treating arthritic disorders |
| 09/04/2002 | EP1235936A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |